ORIC Pharmaceuticals (ORIC) Insider Trading & Ownership → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free ORIC Stock Alerts $9.66 +0.06 (+0.63%) (As of 10:10 AM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability ORIC Pharmaceuticals (NASDAQ:ORIC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.55%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$618,788.40 Get ORIC Insider Trade Alerts Want to know when executives and insiders are buying or selling ORIC Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORIC Insider Buying and Selling by Quarter Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. ORIC Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/6/2024Jacob ChackoCEOSell13,958$12.12$169,170.96 12/15/2023Jacob ChackoCEOSell14,539$8.58$124,744.62 12/15/2023Pratik S MultaniInsiderSell5,282$8.59$45,372.38 7/10/2023Jacob ChackoCEOSell10,508$8.01$84,169.08 7/5/2023Jacob ChackoCEOSell4,336$8.01$34,731.36 6/26/2023Jacob ChackoCEOSell20,000$8.03$160,600.00 (Data available from 1/1/2013 forward) ORIC Insider Trading Activity - Frequently Asked Questions Who is on ORIC Pharmaceuticals's Insider Roster? The list of insiders at ORIC Pharmaceuticals includes Dominic Piscitelli, Jacob Chacko, Pratik S Multani, Richard A Heyman, and Richard H Scheller. Learn more on insiders at ORIC. What percentage of ORIC Pharmaceuticals stock is owned by insiders? 5.55% of ORIC Pharmaceuticals stock is owned by insiders. Learn more on ORIC's insider holdings. Which ORIC Pharmaceuticals insiders have been buying company stock? The following insider purchased ORIC shares in the last 24 months: Jacob Chacko ($1,097,787.64). How much insider buying is happening at ORIC Pharmaceuticals? Insiders have purchased a total of 380,646 ORIC shares in the last 24 months for a total of $1,097,787.64 bought. Which ORIC Pharmaceuticals insiders have been selling company stock? The following insiders have sold ORIC shares in the last 24 months: Jacob Chacko ($592,149.02), and Pratik S Multani ($52,161.63). How much insider selling is happening at ORIC Pharmaceuticals? Insiders have sold a total of 76,476 ORIC Pharmaceuticals shares in the last 24 months for a total of $644,310.65 sold. More Insider Trading Tools from MarketBeat Related Companies: Nurix Therapeutics Insider Buying Wave Life Sciences Insider Buying Zymeworks Insider Buying Mineralys Therapeutics Insider Buying Stoke Therapeutics Insider Buying Cogent Biosciences Insider Buying Olema Pharmaceuticals Insider Buying SIGA Technologies Insider Buying IGM Biosciences Insider Buying Dianthus Therapeutics Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:ORIC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.